[Pilot study of the effect of intravenous prostavasin therapy of inpatients with diabetes mellitus and IIb arterial occlusive disease].
Rosak
C
C
Krankenhaus Sachsenhausen, C. v.Noordenklinik, Frankfurt am Main.
Hofmann
U
U
König
P
P
Nitsche
G B
GB
D000527:Alprostadil / Q000008:administration & dosage*; D001157:Arterial Occlusive Diseases / Q000188:drug therapy*; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D003925:Diabetic Angiopathies / Q000188:drug therapy*; D003930:Diabetic Retinopathy / Q000188:drug therapy; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects
D000527:Alprostadil
Pilotstudie zum Einfluss einer intravenösen PROSTAVASIN-Therapie bei stationären Patienten mit Diabetes mellitus und AVK IIb.